Back to search

Article

“Transcriptomic Profiling Unveils Novel Therapeutic Options for Drug-Resistant Temporal Lobe Epilepsy”

2024-06-26

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Epilepsy drug treatments fail in 25-30% of patients, who then develop drug resistance. Temporal lobe epilepsy is the most prevalent subtype associated with drug resistance. Classical drug discovery is a long and extremely costly process with a high rate of failure in clinical trials. Drug repurposing is a more cost- and time-effective strategy. Hence, the main objective of thi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
930e847d-47e9-53d2-b570-78b6c133efd5
DOI
10.1101/2024.06.26.24309519
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
“Transcriptomic Profiling Unveils Novel Therapeutic Options for Drug-Resistant Temporal Lobe Epilepsy”DOI 10.1101/2024.06.26.24309519
Select a neighboring publication to make it the new centre.